A. Amy Davies-Shabazz

A. Amy Davies-Shabazz serves as the Senior Director and US Head of Medical Science Liaisons at Alnylam Pharmaceuticals since October 2021, overseeing the hiring, training, evaluation, and motivation of MSLs to align with corporate strategies. Prior experience includes leadership roles at Revance Therapeutics, Inc., and Genentech, focusing on medical strategy and team development in the fields of aesthetics and infectious diseases. A. Amy has also provided consultancy services through Professional Nurse Consultants, LLC, and held key positions at Keryx Biopharmaceuticals and Boehringer Ingelheim, where responsibilities included field medical strategy, KOL engagement, and educational material development. A. Amy holds an MBA from Tarleton State University/Texas A&M, a Doctorate in Nursing Science, and a Master's in Nursing from the University of South Carolina, along with a BSN from North Carolina Central University.